ANVISA’s new 2025–2026 Operational Tactical Plan aims to reduce marketing approval backlogs by allowing applicants to replace pending submissions before formal review and by granting priority review for GLP‑1 receptor agonists.

The scientific significance of microbial consortia, their applications in biotechnology, and the challenges of obtaining patent protection in Brazil under BRPTO regulations.

A new chapter in Brazil’s IP scene has begun with the launch of RNA Law, an elite boutique firm dedicated to IP litigation, prosecution, and transactions.

Encourages sustainable innovation by expediting environmentally friendly patent applications’ examination in Brazil

Rapid growth of Brazil’s medical device market has led to increased patent infringement challenges

Ongoing efforts and innovations in global vaccine development, focusing on emerging technologies

Antes da ampla adoção de computadores quânticos, há necessidade de padronização e desenvolvimento de técnicas de criptografia mais complexas para eliminar riscos à privacidade

Governo lança programa "Mover" para promover sustentabilidade em automóveis, investimentos em P&D e atrair plantas industriais estrangeiras.

Explores patent litigation in Brazil’s growing animal health sector, emphasizing legal challenges

Legislative proposal allowing AI to be recognized as inventors in patent applications in Brazil

Updates on new regulations impacting patent appeals and examinations in Brazil

Projeto de Lei apresentado na Câmara propõe alteração na Lei da Propriedade Industrial

Examines upcoming legal challenges posed by advances in AI and quantum computing

Challenges in securing IP protection, particularly for divisionals in the Brazilian market

Criticism of Brazilian Patent Office’s recent rule changes impacting appeals and examinations